| abstract |
The present disclosure relates to methods of treating autoimmune, respiratory and/or inflammatory disorders by inhalation of roflumilast N-oxide, and pharmaceutical compositions (and therapeutics) for the treatment of autoimmune, respiratory and/or inflammatory diseases and disorders methods of autoimmune, respiratory and/or inflammatory diseases and disorders). The method involves administering roflumilast N-oxide to a patient in need thereof by inhalation. The present disclosure particularly relates to the treatment of asthma and chronic obstructive pulmonary disease (COPD) by inhaled administration of roflumilast N-oxide. |